Holen Sie sich die Stockscreener-App
9.64
2.55%
0.24
Handel nachbörslich:
9.30
-0.34
-3.53%
Schlusskurs vom Vortag:
$9.40
Offen:
$9.38
24-Stunden-Volumen:
101.24K
Relative Volume:
0.28
Marktkapitalisierung:
$83.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.42M
KGV:
-1.721
EPS:
-5.6013
Netto-Cashflow:
$-7.45M
1W Leistung:
-0.52%
1M Leistung:
+34.83%
6M Leistung:
+340.18%
1J Leistung:
-35.73%
1-Tages-Spanne:
$9.32
$9.89
1-Wochen-Bereich:
$9.105
$9.96
52-Wochen-Spanne:
$1.80
$20.63
Cervomed Inc Stock (CRVO) Company Profile
Firmenname
Cervomed Inc
Sektor
Branche
Telefon
(617) 744-4400
Adresse
20 PARK PLAZA, BOSTON
Vergleichen Sie CRVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRVO
Cervomed Inc
|
9.64 | 81.81M | 0 | -6.42M | -7.45M | -5.6013 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Cervomed Inc Stock (CRVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-13 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2024-12-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-12-11 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2024-12-11 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2024-12-10 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-12-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-18 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-07-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2018-03-21 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Cervomed Inc Aktie (CRVO) Neueste Nachrichten
CervoMed Inc. stock chart pattern explainedQuarterly Trade Report & Smart Swing Trading Techniques - Newser
What MACD signals say about CervoMed Inc.Earnings Summary Report & Free Community Consensus Stock Picks - Newser
CervoMed Reports Promising Trial Results and Financial Update - MSN
CervoMed Reports Second Quarter 2025 Financial Results and Provi - GuruFocus
CervoMed Reports Second Quarter 2025 Financial Results and Provides Corporate Updates - TradingView
Breakthrough: CervoMed's Dementia Drug Cuts Disease Progression Risk by 54% in Phase 2b Trial - Stock Titan
CervoMed stock price target raised to $15 from $10 at D. Boral Capital - Investing.com Canada
CervoMed Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
CervoMed 2025 Q2 Earnings Deepening Losses Amid Revenue Decline - AInvest
CervoMed Shares Business and Financial Updates Online - TipRanks
CervoMed to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
CervoMed Reveals Neurologic Treatment Progress: Key Presentation at Major Growth Conference Next Week - Stock Titan
Is CervoMed Inc. stock overvalued or undervaluedDouble or triple returns - Jammu Links News
What is the risk reward ratio of investing in CervoMed Inc. stockUnmatched profit potential - Jammu Links News
What analysts say about CervoMed Inc. stockAchieve breakthrough financial results - Jammu Links News
When is CervoMed Inc. stock expected to show significant growthBreakthrough investment results - Jammu Links News
What are CervoMed Inc. company’s key revenue driversMaximize portfolio value with smart investment plans - Jammu Links News
What is CervoMed Inc. company’s growth strategyFree Stock Market Forecast Reports - Jammu Links News
Should I hold or sell CervoMed Inc. stock in 2025Amplify your gains with low-risk picks - Jammu Links News
What drives CervoMed Inc. stock priceExponential wealth increase - Jammu Links News
Is CervoMed Inc. a growth stock or a value stockHigh-yield trading alerts - Jammu Links News
Is it the right time to buy CervoMed Inc. stockBreakout stock performance - jammulinksnews.com
CervoMed Inc. (NASDAQ:CRVO) Surges 53%; Retail Investors Who Own 48% Shares Profited Along With Insiders - 富途牛牛
CervoMed Shares Surge After Promising Dementia Drug Trial Results - MSN
How volatile is CervoMed Inc. stock compared to the marketSwing Trade Updates For Consistent Profits - Jammu Links News
Leading vs lagging indicators on CervoMed Inc. performanceTrade Scanner With Buy Zone Alerts Flagged - metal.it
CervoMed Dementia Drug Slows Disease Progression In Study: Retail Loads Up On The Stock - Stocktwits
CervoMed Inc. Forms Double Bottom Pattern — Eyes on BreakoutAlpha Driven Watchlist With Alerts Published - metal.it
CERVOMED INC (CRVO) Surges 11.6%: Is This an Indication of Further Gains? - MSN
Sentiment Turns Positive on CervoMed Inc. — Reversal AheadReliable Alerts for Daily Stock Movers Released - metal.it
Canaccord Genuity raises CervoMed stock price target to $27 on improved approval odds - Investing.com Nigeria
CervoMed (CRVO) Target Price Increased Following Positive Drug T - GuruFocus
Published on: 2025-07-29 09:25:15 - metal.it
Canaccord Genuity raises CervoMed stock price target to $27 on improved approval odds By Investing.com - Investing.com South Africa
Will CervoMed Inc. Benefit From Broader Market BounceAI Powered High Return Stock Calls Dominate Watchlists - metal.it
CervoMed Announces 32-Week Data from RewinD-LB Trial - GlobeNewswire
CervoMed Inc. Company’s Quarterly Earnings Growth: What the Numbers SayInvestment Strategy With Predictable Gains Outlined - metal.it
CervoMed Announces Positive Phase 2b Trial Results - TipRanks
CRVO Stock Skyrockets: What’s Next? - StocksToTrade
CervoMed Dementia Drug Slows Disease Progression In Study: Retail Loads Up On The Stock By Stocktwits - Investing.com India
CervoMed's Dementia Data Show Slowed Disease Progression - Benzinga
Why CervoMed Stock is Suddenly Booming - StocksToTrade
CRVO’s New Phase 2b Results: What’s Next? - timothysykes.com
CervoMed Shares Rise on Trial Data for Neflamapimod - 富途牛牛
How to monitor CervoMed Inc. with trend dashboardsFree News Based Entry Opportunity Alerts - Newser
CervoMed Stock Soars 63.36% on Positive Dementia Drug Trial Data - AInvest
CervoMed announces 32-week data from Extension phase of Phase 2b RewinD-LB - TipRanks
Best data tools to analyze CervoMed Inc. stockBuy Candidate Summary Based on Fundamentals - Newser
CervoMed stock soars after positive dementia drug trial data By Investing.com - Investing.com Nigeria
CervoMed stock soars after positive dementia drug trial data - Investing.com Australia
Combining machine learning predictions for CervoMed Inc.Price Spike Prediction for Active Traders - Newser
Finanzdaten der Cervomed Inc-Aktie (CRVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):